Literature DB >> 8174489

[Pneumonectomy combined with partial resection of left atrium in the treatment of stage IIIb bronchogenic carcinoma].

Q H Zhou1.   

Abstract

From April, 1988 to April, 1992, Pneumonectomy combined with resection of a part of left atrium in the treatment of patients with stage IIIb bronchogenic carcinoma was carried out in 5 cases because that the base of the pulmonary vein or adjacent left atrium were invaded by lung cancer. The surgical indications, surgical techniques, and the main points of perioperative management are discussed. The authors emphasize that the left atrium should be resected first before the pulmonary artery and bronchus are divided; that the tumor tissue should be resected completely and the healthy left atrium be reserved if possible; and the resection of the left atrium should not be more than one third of it. Pulmonary edema and respiratory failure often occur in the postoperative period, and its severity and morbidity are heavier than those patients with pneumonectomy alone. Therefore, postoperative management is of great importance. The postoperative survivals in this group are as follows: 2 cases survived more than 4 years; 1 more than 2 years; 1 over 10 months and another one 4 months.

Entities:  

Mesh:

Year:  1993        PMID: 8174489

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].

Authors:  Qinghua Zhou; Yingkang Shi; Jun Chen; Bin Liu; Yun Wang; Daxing Zhu; Hong-Tao Zhang; Peng Xu; Youling Gong; Gang Chen; Sen Wei; Xiaoming Qiu; Zhongxi Niu; Xiaofeng Chen; Zhe Lei; Liang Duan; Zhu Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02

2.  [Experiences of cardiopulmonary bypass in the treatment of locally advanced pulmonary malignant tumors].

Authors:  Yong Luan; Qingwei Tan; Xiaoming Bian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.